 Sarahanne Hope
Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aorta | 10 | 2009 | 440 | 1.550 |
Why?
| | Blood Pressure | 12 | 2013 | 1779 | 1.010 |
Why?
| | Arteries | 3 | 2008 | 261 | 0.630 |
Why?
| | Pulsatile Flow | 4 | 2009 | 61 | 0.540 |
Why?
| | Systole | 4 | 2013 | 181 | 0.520 |
Why?
| | Blood Pressure Determination | 4 | 2009 | 145 | 0.490 |
Why?
| | Models, Cardiovascular | 2 | 2008 | 196 | 0.420 |
Why?
| | Ventricular Function, Left | 2 | 2013 | 542 | 0.370 |
Why?
| | Cardiovascular Diseases | 4 | 2009 | 2187 | 0.320 |
Why?
| | Coronary Artery Disease | 3 | 2007 | 749 | 0.320 |
Why?
| | Heart Rate | 4 | 2012 | 855 | 0.260 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 2 | 2003 | 42 | 0.230 |
Why?
| | Cardiovascular Agents | 1 | 2007 | 166 | 0.230 |
Why?
| | Hypercholesterolemia | 2 | 2004 | 95 | 0.220 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2005 | 92 | 0.210 |
Why?
| | Cell Adhesion Molecules | 2 | 2006 | 181 | 0.190 |
Why?
| | Rheumatic Fever | 1 | 2022 | 6 | 0.190 |
Why?
| | Rheumatic Heart Disease | 1 | 2022 | 5 | 0.190 |
Why?
| | Central Venous Pressure | 1 | 2002 | 17 | 0.190 |
Why?
| | Coronary Angiography | 4 | 2011 | 328 | 0.190 |
Why?
| | Antihypertensive Agents | 1 | 2006 | 519 | 0.180 |
Why?
| | Diabetic Angiopathies | 1 | 2004 | 264 | 0.180 |
Why?
| | Heart Rupture | 1 | 2021 | 5 | 0.170 |
Why?
| | Pericardial Effusion | 1 | 2021 | 22 | 0.170 |
Why?
| | Myocarditis | 1 | 2022 | 102 | 0.170 |
Why?
| | Aneurysm, False | 1 | 2021 | 46 | 0.160 |
Why?
| | Sleep Apnea Syndromes | 2 | 2012 | 98 | 0.160 |
Why?
| | C-Reactive Protein | 1 | 2002 | 422 | 0.150 |
Why?
| | Radial Artery | 3 | 2004 | 75 | 0.150 |
Why?
| | Hypertension | 4 | 2011 | 1273 | 0.130 |
Why?
| | Humans | 30 | 2022 | 145475 | 0.120 |
Why?
| | Heart Ventricles | 1 | 2021 | 756 | 0.120 |
Why?
| | Pulse | 2 | 2007 | 29 | 0.120 |
Why?
| | Reproducibility of Results | 5 | 2010 | 3413 | 0.110 |
Why?
| | Male | 21 | 2014 | 72843 | 0.110 |
Why?
| | Risk Assessment | 1 | 2005 | 3747 | 0.110 |
Why?
| | Down Syndrome | 2 | 2012 | 525 | 0.100 |
Why?
| | Coronary Stenosis | 2 | 2011 | 40 | 0.100 |
Why?
| | Female | 21 | 2021 | 78845 | 0.100 |
Why?
| | Tetralogy of Fallot | 1 | 2013 | 78 | 0.090 |
Why?
| | Fontan Procedure | 1 | 2014 | 192 | 0.090 |
Why?
| | Mitral Valve | 1 | 2012 | 95 | 0.090 |
Why?
| | Pulse Wave Analysis | 1 | 2012 | 267 | 0.090 |
Why?
| | Fractional Flow Reserve, Myocardial | 1 | 2011 | 10 | 0.090 |
Why?
| | Carotid Arteries | 1 | 2012 | 208 | 0.080 |
Why?
| | Sympathetic Nervous System | 1 | 2012 | 181 | 0.080 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2011 | 50 | 0.080 |
Why?
| | Regression Analysis | 2 | 2004 | 1001 | 0.080 |
Why?
| | Autonomic Nervous System Diseases | 1 | 2011 | 37 | 0.080 |
Why?
| | Cardiovascular System | 1 | 2012 | 138 | 0.080 |
Why?
| | Aged | 10 | 2011 | 26153 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 2 | 2011 | 2769 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2011 | 2930 | 0.080 |
Why?
| | Sleep Apnea, Obstructive | 2 | 2011 | 302 | 0.080 |
Why?
| | Myocardial Ischemia | 1 | 2011 | 285 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2004 | 2588 | 0.070 |
Why?
| | Arousal | 1 | 2010 | 157 | 0.070 |
Why?
| | Victoria | 2 | 2022 | 22 | 0.070 |
Why?
| | Middle Aged | 10 | 2011 | 36215 | 0.070 |
Why?
| | Ultrasonography | 1 | 2012 | 785 | 0.070 |
Why?
| | Bundle-Branch Block | 1 | 2008 | 37 | 0.070 |
Why?
| | Elasticity | 1 | 2009 | 189 | 0.070 |
Why?
| | Endothelium, Vascular | 2 | 2012 | 956 | 0.070 |
Why?
| | Proportional Hazards Models | 2 | 2014 | 1327 | 0.070 |
Why?
| | Australia | 2 | 2022 | 288 | 0.070 |
Why?
| | Vascular Stiffness | 1 | 2012 | 486 | 0.070 |
Why?
| | Compliance | 1 | 2007 | 50 | 0.060 |
Why?
| | Cardiac Surgical Procedures | 1 | 2013 | 610 | 0.060 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2008 | 143 | 0.060 |
Why?
| | Biomarkers | 4 | 2012 | 4295 | 0.060 |
Why?
| | Atenolol | 1 | 2006 | 8 | 0.060 |
Why?
| | Amlodipine | 1 | 2006 | 10 | 0.060 |
Why?
| | Follicular Fluid | 1 | 2006 | 6 | 0.060 |
Why?
| | Brachial Artery | 2 | 2006 | 208 | 0.060 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2007 | 196 | 0.060 |
Why?
| | Cacao | 1 | 2006 | 7 | 0.060 |
Why?
| | Heart Defects, Congenital | 1 | 2014 | 910 | 0.060 |
Why?
| | Aorta, Thoracic | 1 | 2009 | 286 | 0.060 |
Why?
| | Flavonols | 1 | 2006 | 27 | 0.060 |
Why?
| | Glycosaminoglycans | 1 | 2006 | 79 | 0.060 |
Why?
| | Beverages | 1 | 2006 | 68 | 0.060 |
Why?
| | Ovarian Follicle | 1 | 2006 | 78 | 0.060 |
Why?
| | Proteoglycans | 1 | 2006 | 112 | 0.060 |
Why?
| | Polysomnography | 3 | 2012 | 239 | 0.060 |
Why?
| | Pravastatin | 1 | 2005 | 45 | 0.060 |
Why?
| | Fourier Analysis | 1 | 2005 | 42 | 0.060 |
Why?
| | Angina, Unstable | 1 | 2005 | 83 | 0.060 |
Why?
| | Prospective Studies | 3 | 2011 | 8057 | 0.060 |
Why?
| | Risk Factors | 4 | 2008 | 10885 | 0.060 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2006 | 252 | 0.050 |
Why?
| | Electrocardiography | 1 | 2008 | 665 | 0.050 |
Why?
| | Catheter Ablation | 1 | 2008 | 355 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2006 | 848 | 0.050 |
Why?
| | Calibration | 1 | 2004 | 152 | 0.050 |
Why?
| | Adult | 7 | 2021 | 40777 | 0.050 |
Why?
| | Biomechanical Phenomena | 1 | 2007 | 857 | 0.050 |
Why?
| | P-Selectin | 1 | 2003 | 29 | 0.050 |
Why?
| | Stroke Volume | 1 | 2006 | 654 | 0.050 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2003 | 132 | 0.050 |
Why?
| | Sleep | 1 | 2010 | 888 | 0.050 |
Why?
| | Reference Values | 1 | 2004 | 798 | 0.050 |
Why?
| | Diastole | 1 | 2002 | 146 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2007 | 1061 | 0.040 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 443 | 0.040 |
Why?
| | Cardiac Tamponade | 1 | 2021 | 15 | 0.040 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2004 | 449 | 0.040 |
Why?
| | Epinephrine | 2 | 2012 | 158 | 0.040 |
Why?
| | Norepinephrine | 2 | 2012 | 201 | 0.040 |
Why?
| | Sex Factors | 2 | 2008 | 2105 | 0.040 |
Why?
| | Research Design | 1 | 2007 | 1137 | 0.040 |
Why?
| | Cardiac Catheterization | 1 | 2004 | 558 | 0.040 |
Why?
| | Pacemaker, Artificial | 2 | 2014 | 128 | 0.040 |
Why?
| | Fetal Diseases | 1 | 2021 | 194 | 0.040 |
Why?
| | Acute Disease | 1 | 2002 | 1036 | 0.040 |
Why?
| | Cesarean Section | 1 | 2021 | 230 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2021 | 11772 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2014 | 5423 | 0.030 |
Why?
| | Myocardial Infarction | 1 | 2005 | 1210 | 0.030 |
Why?
| | Comorbidity | 1 | 2022 | 1661 | 0.030 |
Why?
| | Child, Preschool | 4 | 2013 | 11853 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2009 | 3904 | 0.030 |
Why?
| | Child | 4 | 2022 | 22707 | 0.030 |
Why?
| | Dextrocardia | 1 | 2014 | 4 | 0.030 |
Why?
| | New Zealand | 1 | 2014 | 54 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2022 | 2803 | 0.030 |
Why?
| | Tachycardia, Supraventricular | 1 | 2014 | 49 | 0.030 |
Why?
| | Cyanosis | 1 | 2013 | 18 | 0.030 |
Why?
| | Vaccination | 1 | 2022 | 1426 | 0.020 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2014 | 118 | 0.020 |
Why?
| | Thromboembolism | 1 | 2014 | 129 | 0.020 |
Why?
| | Catecholamines | 1 | 2012 | 88 | 0.020 |
Why?
| | Adolescent | 3 | 2022 | 22530 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2014 | 969 | 0.020 |
Why?
| | Pulmonary Valve | 1 | 2013 | 102 | 0.020 |
Why?
| | Snoring | 1 | 2011 | 19 | 0.020 |
Why?
| | Myocardial Revascularization | 1 | 2011 | 85 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1374 | 0.020 |
Why?
| | Time Factors | 1 | 2002 | 7123 | 0.020 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2013 | 198 | 0.020 |
Why?
| | Double-Blind Method | 2 | 2006 | 2062 | 0.020 |
Why?
| | Reoperation | 1 | 2013 | 633 | 0.020 |
Why?
| | Echocardiography | 1 | 2013 | 647 | 0.020 |
Why?
| | Observer Variation | 1 | 2011 | 357 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2022 | 17291 | 0.020 |
Why?
| | Electromyography | 1 | 2012 | 419 | 0.020 |
Why?
| | Sleep, REM | 1 | 2010 | 44 | 0.020 |
Why?
| | Dopamine | 1 | 2012 | 295 | 0.020 |
Why?
| | Autonomic Nervous System | 1 | 2010 | 82 | 0.020 |
Why?
| | Adenosine | 1 | 2011 | 255 | 0.020 |
Why?
| | Vasodilator Agents | 1 | 2011 | 330 | 0.020 |
Why?
| | Electroencephalography | 1 | 2012 | 561 | 0.020 |
Why?
| | Manometry | 1 | 2009 | 98 | 0.020 |
Why?
| | Linear Models | 1 | 2011 | 845 | 0.020 |
Why?
| | Pregnancy | 1 | 2021 | 7202 | 0.020 |
Why?
| | Blood Flow Velocity | 1 | 2009 | 421 | 0.020 |
Why?
| | Oxygen | 1 | 2012 | 978 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2009 | 368 | 0.020 |
Why?
| | Digestion | 1 | 2006 | 10 | 0.020 |
Why?
| | Dialysis | 1 | 2006 | 19 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1997 | 0.020 |
Why?
| | Osmosis | 1 | 2006 | 22 | 0.020 |
Why?
| | Chromatography, Ion Exchange | 1 | 2006 | 57 | 0.020 |
Why?
| | Enzymes | 1 | 2006 | 60 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 331 | 0.010 |
Why?
| | Forearm | 1 | 2006 | 141 | 0.010 |
Why?
| | Microcirculation | 1 | 2006 | 142 | 0.010 |
Why?
| | Registries | 1 | 2014 | 2406 | 0.010 |
Why?
| | Vascular Resistance | 1 | 2006 | 370 | 0.010 |
Why?
| | Palliative Care | 1 | 2013 | 1020 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 2006 | 514 | 0.010 |
Why?
| | Cattle | 1 | 2006 | 946 | 0.010 |
Why?
| | Blotting, Western | 1 | 2006 | 1179 | 0.010 |
Why?
| | Vasodilation | 1 | 2006 | 521 | 0.010 |
Why?
| | Cell Membrane | 1 | 2006 | 707 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2010 | 3623 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2014 | 2970 | 0.010 |
Why?
| | Hemodynamics | 1 | 2006 | 1118 | 0.010 |
Why?
| | Age Factors | 1 | 2008 | 3342 | 0.010 |
Why?
| | Logistic Models | 1 | 2005 | 2134 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1435 | 0.010 |
Why?
| | Infant | 1 | 2013 | 10077 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 8333 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 14219 | 0.010 |
Why?
| | Inflammation | 1 | 2005 | 2878 | 0.010 |
Why?
| | Animals | 1 | 2006 | 38030 | 0.000 |
Why?
|
|
Hope's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|